Executive Summary
Overnight SEC filings reveal a quiet pre-market session dominated by preliminary earnings disclosures (Item 2.02 across ~15 filers), widespread executive changes (Item 5.02 in ~20 companies spanning biotech, energy, and finance), and vague 'Other Events' (Item 8.01 in over 25 cases), with all but one maintaining neutral sentiment. A single high-materiality bearish flag emerges from an undisclosed company's non-reliance on prior financials (Item 4.02), signaling potential accounting weaknesses amid M&A activity. Cumulative impact suggests low systemic volatility at open, but portfolio managers should monitor leadership churn for governance risks and probe high-materiality M&A (e.g., MOBIX Labs, D-Wave) for alpha.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from January 05, 2026.
Investment Signals(3)
- ▲
Cluster of preliminary earnings releases without red flags [NEUTRAL-to-BULLISH] - UniFirst Corp, BTCS Inc., Albertsons Companies, Apogee Enterprises
- ▲
Multiple material definitive agreements hinting at strategic growth [BULLISH] - MOBIX Labs, Archrock, D-Wave Quantum, COMPASS Pathways
- ▲
High executive turnover without disclosed distress signals [NEUTRAL-to-BEARISH] - CF Industries, NRG Energy, FuelCell Energy, Extreme Networks
Risk Flags(3)
- ▼
Non-reliance on previously issued financial statements signals material accounting/control weaknesses [BEARISH, HIGH MATERIALITY] - Unknown Company (AccNo: 0001185185-26-000046)
- ▼
Widespread C-suite changes across 20+ filers raise governance instability concerns, potentially amplifying operational risks in volatile sectors like biotech and energy
- ▼
Unregistered equity sales in M&A contexts (Items 3.02) pose dilution threats without quantified impacts [MEDIUM RISK] - VisionWave Holdings, D-Wave Quantum
Opportunities(3)
- ◆
Strategic M&A announcements in tech/quantum and energy sectors offer takeover premiums or synergies upon exhibit review [ALPHA] - MOBIX Labs (Materiality 8/10), D-Wave Quantum (7/10), Archrock (7/10)
- ◆
Biotech cluster (e.g., Processa, Rapport, Adicet) with Regulation FD disclosures may reveal pipeline catalysts for event-driven trades
- ◆
Earnings previews from consumer/retail names (Albertsons, Cinemark) provide early sector readouts absent downside surprises
Sector Themes(3)
- Biotech/Pharma deluge (~12 filers◆
4D Molecular, Ionis, Monte Rosa, EyePoint) with Other Events and Reg FD points to clinical/strategic updates amid leadership shifts, signaling sector rotation potential
- ◆
Executive churn wave in Energy/Infrastructure (Clearway, Archrock, NRG, FuelCell) correlates with M&A, hinting at consolidation amid energy transition pressures
- ◆
Financials/BDCs (Blue Owl entities, National Bank Holdings) mix earnings and acquisitions, reflecting yield-seeking resilience in a neutral tape
Watch List(4)
- 👁
Unknown Company (Item 4.02 Non-Reliance) - Potential restatement cascade or M&A accounting scandal could trigger broader market contagion
- 👁
MOBIX Labs & D-Wave Quantum (Item 1.01 Agreements) - Unpack exhibits for dilution details and partnership economics pre-open
- Apogee Enterprises (Dual filings👁
Earnings + Exec Change) - Cross-verify financials against leadership transition for Q guidance risks
- 👁
Biotech Exec Changers (SAB Biotherapeutics, Centessa, Genprex) - Monitor for pipeline or funding ripple effects in high-beta sector
Filing Analyses(66)
07-01-2026
Signing Day Sports, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-001978, Size: 260 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with limited public information available.
07-01-2026
WHITE MOUNTAINS INSURANCE GROUP LTD filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001102, Size: 138 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
THUMZUP MEDIA Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000727, Size: 18 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or financial statements are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Digi Power X Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-001966, Size: 238 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. Sector is not specified.
07-01-2026
LM Funding America, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005468, size 224 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure.
07-01-2026
California BanCorp (CA) filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000728, Size: 360 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Zeo ScientifiX, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001829126-26-000073, size 300 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Processa Pharmaceuticals, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000733, size: 200 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
07-01-2026
Versant Media Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000950103-26-000204, Size: 429 KB), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. Sector not specified. No specific details on the nature of amendments, changes, or exhibits provided in the filing summary.
07-01-2026
Rapport Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005499, Size: 195 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
UniFirst Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005469, Size: 1 MB), reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market. No specific revenue, earnings, transaction values, or other financial metrics are mentioned.
07-01-2026
4D Molecular Therapeutics, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005470, Size: 164 KB). The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on officers, reasons, financial metrics, or changes are provided.
07-01-2026
MOBIX LABS, INC filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000731, Size: 704 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. Sector is not specified.
07-01-2026
Moleculin Biotech, Inc. filed a Form 8-K on January 07, 2026, under Item 8.01 Other Events. Accession number: 0001437749-26-000695. File size: 164 KB. No specific details on the event, transaction, or financial impacts are disclosed.
07-01-2026
SAB Biotherapeutics, Inc. disclosed an officer change via Form 8-K filed on January 07, 2026 (AccNo: 0001193125-26-005487, Size: 268 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.
07-01-2026
Tredegar Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005481, Size: 133 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, appointment or resignation status, reasons, individuals involved, or quantitative data are provided in the summary. Sector is not specified.
07-01-2026
BTCS Inc. filed an 8-K on January 07, 2026 (AccNo: 0001493152-26-000734, Size: 268 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, transaction values, or other quantitative metrics are mentioned in the provided filing summary. Sector is not specified.
07-01-2026
Blue Owl Capital Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005489, Size: 145 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing disclosing financial results with no specific revenue, earnings, transaction values, or other quantitative metrics provided in the summary. Sector is not specified.
07-01-2026
VisionWave Holdings, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001731122-26-000018, Size: 438 KB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and provides financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or strategic rationale are disclosed.
07-01-2026
CION Investment Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001616, Size: 288 KB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary.
07-01-2026
Worthington Enterprises, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005501, Size: 189 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no numerical data or strategic details provided.
07-01-2026
Blue Owl Technology Finance Corp. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005488, Size: 147 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a US market event. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
07-01-2026
Adicet Bio, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005486, Size: 225 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other content are disclosed in the provided filing summary. Sector not specified.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001544, Size: 327 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is classified as a General Filing from us_sec with no sector specified. No details on the specific event, transaction, financial statements, or exhibits are provided.
07-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000717, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or exhibits are provided in the filing summary. Sector not specified.
07-01-2026
Clearway Energy, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001542, Size: 382 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
07-01-2026
CF Industries Holdings, Inc. disclosed an Officer Change event via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001551, Size: 190 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the available summary.
07-01-2026
National Bank Holdings Corp filed an 8-K on 2026-01-07 (AccNo: 0001104659-26-001549, Size: 264 KB) announcing completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure or election of directors/officers and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, valuation, structure, or financial metrics are disclosed.
07-01-2026
Ionis Pharmaceuticals Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001140361-26-000435, Size: 191 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.
07-01-2026
Biohaven Ltd. filed a Form 8-K on January 7, 2026 (AccNo: 0001935979-26-000002, Size: 131 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
News Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001564708-26-000004, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or financial statements/exhibits are disclosed. Sector not specified.
07-01-2026
Diversified Energy Co filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000434, Size: 284 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the available information. Sector not specified.
07-01-2026
Centessa Pharmaceuticals plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-004896, Size: 361 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data such as transaction values, share counts, or percentages are disclosed in the provided information. Sector is not specified.
07-01-2026
Archrock, Inc. filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001481, Size: 618 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing from US SEC source in an unspecified sector. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided information.
07-01-2026
Comstock Inc. filed a Form 8-K on January 07, 2026, reporting under Item 8.01 Other Events. The filing has accession number 0001437749-26-000673 and size of 160 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
07-01-2026
TECOGEN INC. filed a General Filing (Form 8-K) on January 07, 2026 (AccNo: 0001537435-26-000003, Size: 134 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on the disclosure content, events, transactions, or financial impacts are provided in the filing summary. Sector not specified.
07-01-2026
Cinemark Holdings, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-004875, Size: 260 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard financial results disclosure for a US equity market company in an unspecified sector. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
07-01-2026
Cal-Maine Foods Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001562762-26-000002, size 323 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided filing summary. Sector not specified.
07-01-2026
Sow Good Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-004866, Size: 198 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment or resignation, reasons, or any quantitative data are provided. Event dated January 07, 2026; sector not specified.
07-01-2026
Rezolute, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001556, Size: 6 MB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure of material nonpublic information with attached exhibits, but no specific core event, transaction details, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
GameStop Corp. filed a Form 8-K on January 07, 2026 (AccNo: 0001326380-26-000004, Size: 244 KB) as a General Filing from us_sec. The filing reports under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No sector is specified, and no further details on events, transactions, or financials are provided.
07-01-2026
COMPASS Pathways plc filed a Form 8-K on January 07, 2026 (AccNo: 0001816590-26-000004), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing likely within the required 4-business-day window.
07-01-2026
Aon plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005392, Size: 406 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided.
07-01-2026
MSC Industrial Direct Co Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001003078-26-000010, Size: 486 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a mandatory earnings-related disclosure.
07-01-2026
PSQ Holdings, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001573, size 396 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, named individuals, quantitative financial metrics, or governance impacts are NOT_DISCLOSED. Sector not specified.
07-01-2026
Albertsons Companies, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001646972-26-000007, Size: 555 KB) disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement with no specific numerical financial metrics, transaction details, or other quantitative data provided in the filing summary. Sector not specified.
07-01-2026
Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005420), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but specific details of the core events, transactions, or exhibits are not disclosed in the provided filing summary. No quantitative data, named entities beyond the filer, or financial impacts are mentioned.
07-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0000006845-26-000005, Size: 1 MB) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results disclosure. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.
07-01-2026
EyePoint Pharmaceuticals, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005418, Size: 340 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, revenue figures, earnings, or other quantitative details are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.
07-01-2026
Compass, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001563190-26-000005, size 1 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC, with sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the provided filing summary.
07-01-2026
Genprex, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000694, Size: 8 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Criteo S.A. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005427, Size: 208 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and material impacts are NOT_DISCLOSED.
07-01-2026
BridgeBio Oncology Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005425), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure of unspecified other events.
07-01-2026
SharkNinja, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001957132-26-000003, Size: 155 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are disclosed in the provided summary. Sector is not specified.
07-01-2026
Anywhere Real Estate Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005430, size: 152 KB) under Item 8.01 Other Events. This is a general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.
07-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000006845-26-000006, Size: 522 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are explicitly stated. No quantitative financial metrics, transaction values, share counts, or percentages are mentioned.
07-01-2026
D-Wave Quantum Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001907982-26-000010, Size: 41 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, parties involved, financial impacts, or other quantitative data disclosed in the provided summary. Sector is not specified.
07-01-2026
W. P. Carey Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001025378-26-000005, Size: 360 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no details provided on the content of the Regulation FD disclosure or specific financial statements/exhibits. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.
07-01-2026
NRG Energy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001602, Size: 276 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary.
07-01-2026
The company filed an 8-K on 2026-01-07 (AccNo: 0001185185-26-000046, Size: 197 KB) under Item 4.02 announcing non-reliance on previously issued financial statements or a related audit report or completed interim review. This event is typed as Merger/Acquisition with no sector specified. No parties, deal structure, valuation, or financial metrics are disclosed.
07-01-2026
InterDigital, Inc. filed a Form 8-K on January 7, 2026, under Item 8.01 Other Events. Accession Number: 0001628280-26-001101. File size: 139 KB. No specific event details, transaction values, or financial metrics disclosed in the provided filing summary.
07-01-2026
Extreme Networks Inc. (EXTREME NETWORKS INC) filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005441, Size: 160 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment/resignation status, reasons, or quantitative data such as compensation amounts, share counts, or transaction values are provided in the filing summary. Sector is not specified.
07-01-2026
Rapport Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005446, Size: 25 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No details on the core events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
07-01-2026
CoStar Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001057352-26-000004, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, names, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Anterix Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001304492-26-000002, Size: 142 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or terms are disclosed in the provided summary. Sector is not specified.
07-01-2026
FUELCELL ENERGY INC filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001597, Size: 282 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector not specified.
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 66 filings
🇺🇸 More from United States
View all →March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings